• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4613486)   Today's Articles (1014)   Subscriber (49387)
For: Osipenko L, Potey P, Perez B, Kupryjanczuk A, Angelov F, Schuster A, Mossialos E. Provenance and Clinical Benefit of Medicines Introduced to the French Market, 2008 to 2018. JAMA Intern Med 2024;184:46-52. [PMID: 37983026 PMCID: PMC10660249 DOI: 10.1001/jamainternmed.2023.6249] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/16/2023] [Accepted: 09/28/2023] [Indexed: 11/21/2023]
Number Cited by Other Article(s)
1
Moore AIG, Beattie A, Ramagopalan SV. Does Industry Really Develop Less Medicines With Clinical Benefit? JAMA Intern Med 2024;184:586-587. [PMID: 38526459 DOI: 10.1001/jamainternmed.2024.0177] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/26/2024]
2
Osipenko L. Does Industry Really Develop Less Medicine With Clinical Benefit?-Reply. JAMA Intern Med 2024;184:587. [PMID: 38526468 DOI: 10.1001/jamainternmed.2024.0180] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 03/26/2024]
3
Errors in Figure 2. JAMA Intern Med 2024;184:228. [PMID: 38190174 PMCID: PMC10844992 DOI: 10.1001/jamainternmed.2023.7794] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/09/2024]
PrevPage 1 of 1 1Next
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA